Adani Green Energy ranked top in NSE ESG ratings for power-utilities sector

Adani Green Energy Limited (AGEL) has been ranked first in the ESG (Environmental, Social, and Governance) ratings in utilities/ power sector by NSE Sustainability Ratings & Analytics Ltd, an entity of the National Stock Exchange (NSE).
Additionally, AGEL is also among the top five entities in ESG ratings assessed from the top 100 listed companies by revenue across the NSE.
NSE recently launched its ESG ratings for listed companies.
NSE's Rating Rationale states AGEL performs well across environment, social and governance parameters. Environmental initiatives are well-integrated, supported by socially responsible practices and effective governance. It demonstrates a mature sustainability approach.
According to NSE Sustainability Ratings & Analytics Ltd, AGEL received an impressive ESG score of 74, the highest within the utilities and power sector. This underscores AGEL's commitment to sustainable practices and its continuous efforts to uphold environmental, social, and governance standards.
AGEL excelled in governance with a score of 76, reflecting the company's robust governance practices, well-organised board structure, and ethical conduct. Its mature approach to risk management further highlights AGEL's commitment to transparency and accountability.
Gautam Adani, Chairman of the Adani Group, highlighted AGEL's dedication to governance and sustainability in its FY25 annual report, stating, "Our governance is of global standards, and our compliance frameworks are robust and non-negotiable." The company also earned a high social score of 73, demonstrating its focus on health and safety measures for employees, customer safety, and community welfare initiatives. AGEL's responsible sourcing and efficient supply chain management further reinforced its position as a leader in socially responsible practices.
NSE Sustainability Ratings & Analytics Ltd evaluates companies based on over 2,000 data points, providing a transparent and materiality-based methodology aligned with national and international standards. AGEL's performance reflects its strategy, culture, and values centred on sustainable practices.
The Securities and Exchange Board of India (SEBI) officially approved NSE Sustainability Ratings & Analytics Ltd as a Category 1 ESG Ratings provider on August 13, 2024, further validating the credibility of these assessments.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Standard

28 minutes ago

• Business Standard

Influx Healthtech IPO booked 200x; check allotment, GMP, listing date

Influx Healthtech IPO allotment status: The basis of allotment of shares for Influx Healthtech is expected to be finalised today, Monday, June 23, 2025. The initial public offering (IPO) of Influx Healthtech, which closed for subscription on Friday, June 20, received a robust response from investors, with the offering being over subscribed by over 201 times. Investors bid for 817.53 million equity shares, which was 201.4 times the public issue size of 4.05 million shares, through 220,338 applications. After the allotment process is completed, investors can verify their IPO allotment status by visiting the official websites of the National Stock Exchange (NSE) and Maashitla Securities, the designated registrar for the Influx Healthtech IPO. Alternatively, they can use the direct links provided below to check their allotment status online: Check Influx Healthtech IPO allotment status on NSE: Check Influx Healthtech IPO allotment status on Maashitla Securities: Influx Healthtech IPO grey market premium (GMP) The unlisted shares of Influx Healthtech were trading at ₹118 in the grey market, commanding a premium of ₹22 or 22.3 per cent compared to the upper price band of ₹96 per share, according to sources tracking unofficial markets. Influx Healthtech IPO details The Mumbai-based company aims to raise ₹58.57 crore through a combination of a fresh issue of 5 million equity shares and an offer for sale (OFS) of 1.1 million equity shares at a price band of ₹91-96 per share. Shares of Influx Healthtech are scheduled to be listed on the NSE SME platform on Wednesday, June 25. Rarever Financial Advisors is the sole book-running lead manager. According to the red herring prospectus (RHP), the company intends to use the net fresh issue proceeds for the set up of the manufacturing facility Nutraceutical Division, a manufacturing facility for the Veterinary Food Division; purchase of machinery for Homecare and Cosmetic Division, and general corporate purposes. About Influx Healthtech Incorporated in 2020, Mumbai-based Influx Healthtech is a healthcare-focused company specialising in contract manufacturing. It operates a manufacturing facility located in Thane, Maharashtra. The company produces Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, care products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables.

Business Standard

28 minutes ago

• Business Standard

Arisinfra Solutions IPO allotment today; check status, GMP, listing date

Arisinfra Solutions IPO allotment status: The basis of allotment for the Arisinfra Solutions IPO shares is likely to be finalised today, Monday, June 23, 2025. The public offering closed for subscription on Friday, June 20, 2025, receiving decent participation from investors and getting oversubscribed by 2.65 times. Here's how to check Arisinfra Solutions IPO online Once the Arisinfra Solutions IPO allotment is finalised, investors can check their status on the official websites of BSE, NSE, or MUFG Intime India (erstwhile Link Intime), the registrar for the issue. Alternatively, investors can use these direct links to check the Arisinfra Solutions IPO allotment status directly: Arisinfra Solutions IPO final subscription status The ₹499.60 crore public offering of Arisinfra Solutions, offered at a price band of ₹210–222 with a lot size of 67 shares, received bids for 3,46,72,835 shares against the 1,30,84,656 shares offered. This led to an oversubscription of 2.65 times by the end of the subscription period, according to data available on the BSE. Arisinfra Solutions IPO witnessed the highest participation from the retail investors who subscribed to 5.59 times the portion reserved for them, non-institutional investors (NIIs) at 3.14 times, and qualified institutional buyers (QIBs) at 1.42 times. Arisinfra Solutions IPO grey market premium (GMP) today According to sources tracking unofficial market activities, the unlisted shares of Arisinfra Solutions were seen trading flat at ₹222 per share. Thus, the grey market premium (GMP) for Arisinfra Solutions IPO remains nil on Monday. Arisinfra Solutions IPO likely listing price Shares of Arisinfra Solutions are scheduled to list on the BSE and NSE on Wednesday, June 25, 2025. The current grey market trends indicate a flat listing of Arisinfra Solutions shares. However, these estimates may vary, as the grey market is unregulated, and GMP should not be considered a reliable indicator of performance. About Arisinfra Solutions Incorporated in 2021, Arisinfra Solutions is a B2B technology-driven platform that simplifies procurement processes for construction and infrastructure companies. The company delivers a range of construction materials, including steel, cement, and aggregates. The company's product portfolio includes GI pipes, MS wire, and OPC bulk cement. Arisinfra Solutions has a subsidiary, ArisUnitern Re Solutions Private, which provides value-added services to real estate developers.

Economic Times

37 minutes ago

• Economic Times

How to trade Nifty after US bombs Iran? Rupak De shares his playbook

The current setup supports a bullish view, with the price likely to move towards 1900. On the lower end, support is placed at 1629. As geopolitical tensions flare with the US bombing Iran and the Israel-Iran conflict deepening, nerves are fraying on Dalal Street. Yet, amid the chaos, Nifty has managed to inch above the stubborn 25,000 mark. Rupak De, Senior Technical Analyst at LKP Securities, breaks down why this level matters now more than ever—and how traders should navigate the monthly expiry and beyond in these high-volatility times. Edited excerpts from a chat: Nifty has been struggling to move sustainably higher than the 25,000-mark for the last few weeks, as visible this time again. On the fundamental side, triggers are missing and the market is worried about Middle East tensions. Will 25,000 remain key support level? For the past month or so, Nifty has been struggling to decisively move past the 25,000 mark. Although it managed to close above this level on multiple occasions, the lack of follow-up buying—mainly due to the volatile geopolitical situation—kept the index oscillating around 25, from being a psychological level, heavy Call writing also acted as a resistance, capping Nifty below 25,000. Now, with Nifty closing 100 points above 25,000, Call writers are feeling the pressure. Sustained trade around this level could trigger short covering in Calls, potentially leading to a further rally. On the downside, 25,000 is now expected to act as the immediate support. Give us your trading strategy for Nifty monthly expiry next week. What are the levels to watch out for? I believe Nifty will remain a 'buy on dips' as long as it stays above 24,850 (December 2024 high). Alternatively, aggressive traders may consider buying the 25,200 Call option above 110, targeting 180, with a stop-loss below 70. With BSE and NSE swapping their expiry days with effect from September, how would your trading strategy change when it comes to index options? With the expiry change, NSE option traders as well as intraday traders are likely to adjust their strategies. Monday will now act like the new Wednesday, as current weekly options will start losing value sharply from Monday itself. Tuesday, being the new expiry day, is expected to see heightened volatility—offering more opportunities for intraday traders. For Nifty weekly option traders, the fastest time decay will now occur between Friday and Monday, due to the weekend effect. As a result, option sellers may find it more favorable to initiate short positions on Friday, depending on other market conditions. For me, it will provide more room to frame strategies involving short options on Friday. For derivative traders, Thursday has been associated with Nifty expiry day for many years. Now with Sensex coming in on Thursday, how do you see trader interest evolving in Sensex contracts? Going forward from September contract when new expiry-day shifting comes into effect, post-policy-day moves could be better captured through BSE options, since most policy announcements (like RBI meetings) typically occur mid-week—making BSE's Thursday expiry more strategically aligned for such plays. The broader market underperformed this week. Are the charts hinting at revival in small and midcaps? Though midcap and smallcap stocks struggled during the week, the latest daily chart closing suggests a decent catch-up rally may be on the cards in the short term, with smaller companies likely to outperform their larger counterparts. Therefore, I expect a smart recovery in the mid and smallcap space in the coming days. Waaree Energies surprised investors on Friday with a sharp 12% jump. How to trade the stock on Monday? After a sharp rally, the risk-reward ratio no longer appears favorable for fresh entries. However, the overall sentiment remains strong, and a buy-on-dips approach would be a better way to enter the stock at the current juncture. Buying near 2,900 with a stop-loss below 2,800 seems like a more prudent strategy. Give us your top ideas for the week ahead. Buy INDUSTOWER @ 404.60 | TGT: 430 | SL: 389 The stock has moved up sharply following a period of sideways consolidation on the daily chart, indicating rising optimism. Moreover, the 21EMA and 50EMA have given a bullish crossover, supporting the positive view. The RSI is in a bullish crossover and rising. The current setup aligns well with a bullish outlook, with the price likely to rise towards 430. On the lower end, support is placed at 389. Buy NAVA @ 565 | TGT: 600 | SL: 539 The stock has given a rounding bottom breakout on the daily chart, suggesting bullishness. In addition, the 21EMA and 50EMA have given a bullish crossover, reinforcing the positive view. The RSI is in a bullish crossover and rising on the hourly chart. The current setup supports a bullish outlook, with the price expected to move towards 600. On the lower end, support is placed at 539. Buy CDSL @ 1680 | TGT: 1900 | SL: 1629 After a brief correction, the stock looks poised to rise again. The price found support at the 21EMA before moving higher, signalling positive sentiment. The RSI is in a bullish crossover and rising on the hourly chart, indicating early signs of strengthening momentum. The current setup supports a bullish view, with the price likely to move towards 1900. On the lower end, support is placed at 1629.